Flu and RSV cases are rising across Greece, mainly affecting children and vulnerable groups, while health officials urge ...

In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...

As the number of RSV infections rises, two recent studies found that protecting babies against the disease prevented ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

Doctors say thousands of people are seeking care for flu symptoms each day as the virus spreads aggressively throughout the ...

How effective is nirsevimab at preventing respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD), ...

Yes, adults can get RSV (respiratory syncytial virus). In fact, most adults have had an RSV infection at least once in their lives. This seasonal virus is so widespread that almost all of us have had ...

A nationwide Danish cohort study reports cardiovascular events up to 1 year after infection, comparable to that observed with influenza. A nationwide Danish cohort study reports cardiovascular events ...

At 365 days, 665 vs 257 any cardiovascular events occurred among cases of RSV infection vs control participants, corresponding to risk differences of 4.69 percentage points (95% CI, 4.02-5.36) for any ...

An expert panel of the European Medicines Agency (EMA) has endorsed expanding the marketing authorization for Arexvy, a vaccine developed by GSK (GSK) against respiratory syncytial virus (RSV) for ...

PHOENIX — Federal health officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, a respiratory virus that routinely impacts pediatric wards across ...

An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually experience RSV as a mild cold, infants can develop more severe conditions, ...